IPAMORELIN + CJC-1295 WITHOUT DAC (MOD GRF 1–29) – Research Grade Peptide

IPAMORELIN + CJC-1295 WITHOUT DAC (MOD GRF 1–29) – Research Grade Peptide Blend

For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, human consumption, clinical use or veterinary use. It must not be used in any way that contravenes applicable laws or the requirements of the Medicines and Healthcare products Regulatory Agency.

• Research-grade Ipamorelin and CJC-1295 without DAC (MOD GRF 1–29) blend supplied for laboratory use only.
• Supplied as a lyophilised powder in sterile, flip-top headspace vials designed for laboratory use.
• Equal-mass formulation, with component quantities specified for the selected vial size.
• Regular and ULTIMATE options for differing laboratory specification requirements.

Product Overview

Research Scientific supplies the Ipamorelin + CJC-1295 without DAC (MOD GRF 1–29) Blend as a two-component research formulation for controlled laboratory handling and analytical work. The peptides are combined in equal amounts by mass and supplied in a lyophilised format.

Refer to the selected product label and batch documentation for the component quantities, formulation details and applicable analytical specification. The stated total peptide quantity applies to an individual vial unless the selected option identifies a multi-vial laboratory pack.

Our Regular blend is intended for routine laboratory work where its documented specification meets the requirements of the intended method. The ULTIMATE option provides an additional specification choice for laboratories requiring further chromatographic purification and more stringent bacterial endotoxin testing.

Chemical Information

• Product name: IPAMORELIN + CJC-1295 WITHOUT DAC (MOD GRF 1–29)
• Product reference: PEP080
• Material type: Two-component research-grade peptide blend.
• Stated blend ratio: Equal amounts of each component by mass.
• Physical presentation: Lyophilised powder.
• Purity specification: Not specified in the supplied product information. Refer to the completed batch Certificate of Analysis for the applicable component specifications, analytical methods and reported results.

Chemical Information – Ipamorelin Component

• Component name: Ipamorelin
• Alternative name in the supplied specification: Ipamorelin acetate.
• Stated Chemical Abstracts Service registry number: 170851-70-4.
• Molecular formula as supplied: C₃₈H₄₉N₉O₅.
• Molecular weight: Not specified in the supplied product information.
• Supplied form: Confirm the peptide identity, salt form, component content basis and any additional formulation ingredients against the relevant manufacturer and batch documentation.

Chemical Information – MOD GRF 1–29 Component

• Component name: MOD GRF 1–29
• Alternative names in the supplied specification: CJC-1295 without DAC; Modified GRF 1–29.
• Stated Chemical Abstracts Service registry number: 863288-34-0.
• Molecular formula as supplied: C₁₅₂H₂₅₂N₄₄O₄₂.
• Molecular weight: Not specified in the supplied product information.
• Supplied form: Identified in the product specification as CJC-1295 without DAC (MOD GRF 1–29). Confirm the exact sequence, terminal modifications and salt form against the relevant manufacturer and batch documentation.

The chemical identifiers above are reproduced from the supplied product specification. Confirm that each name, registry number and molecular formula corresponds to the exact component used in the selected batch, including its stated salt form.

Blended Peptides – Formulated for Laboratory Research

The blend contains Ipamorelin and CJC-1295 without DAC (MOD GRF 1–29) in equal amounts by mass. The stated total peptide quantity is divided equally between these two components.

Illustrative composition: A vial specified as a 2-milligram total blend contains 1 milligram of Ipamorelin and 1 milligram of CJC-1295 without DAC (MOD GRF 1–29).

Refer to the product label and batch documentation for the component content basis and any additional formulation ingredients. Confirm how the stated peptide content relates to the total powder mass for the selected formulation.

Formulation Process and Quality Assurance

Defined peptide ratio: The formulation is prepared to the stated equal-mass composition. Confirm the individual component quantities applicable to the selected vial size against the product label and batch specification.

Formulation consistency: The supplied product description states that the blend is prepared for uniform distribution of its components. Refer to the relevant manufacturing and analytical records for the applicable blend-uniformity specification and supporting results.

Powder preparation: The supplied product specification describes sterile, lyophilised powder that is finely milled and sieved for consistency. Confirm the applicable processing and sterility documentation for the selected product and batch.

Manufacturing information: The product description identifies manufacture in a laboratory in the United Kingdom, the United States or Germany. Refer to the batch-specific supplier documentation for the actual production location and associated quality-control information.

Laboratory Handling and Reconstitution

The supplied product information specifies bacteriostatic water containing 0.9% benzyl alcohol, or a suitable equivalent, for laboratory reconstitution. Confirm compatibility with the complete formulation and the intended analytical method before use.

Follow the manufacturer's instructions and your laboratory's validated procedure when selecting the reconstitution medium, concentration and handling conditions for the finished blend.

Follow the handling, storage and disposal instructions provided with the product. Research Scientific does not provide advice or recommendations regarding dosage, administration or use in humans or animals.

Batch Documentation and Delivery

Batch documentation: Available manufacturer and analytical records are provided where supplied. Match the documentation to the selected product, grade and batch before relying on it for laboratory quality assessment.

Certificate of Analysis: Refer to the relevant completed batch certificate for the tests performed, analytical methods, reported results and applicable specifications. Use the product documentation link or the code provided on the packaging to access the available document.

Safety Data Sheet: Consult the current, formulation-specific Safety Data Sheet for information supporting laboratory risk assessment, safe handling, storage and disposal.

Tracked delivery: Securely packaged and dispatched frozen in insulated packaging using a tracked delivery service. Follow the storage instructions supplied with the product upon receipt.

Product Documentation

View Ipamorelin + CJC-1295 Without DAC (MOD GRF 1–29) Blend Certificate of Analysis

View Ipamorelin + CJC-1295 Without DAC (MOD GRF 1–29) Blend Safety Data Sheet

---

For Research Use Only
This product is supplied strictly for scientific laboratory research and analytical purposes. Neither the Regular nor the ULTIMATE option is intended for human or animal use, human consumption, clinical use or therapeutic application.